SUCCESSFUL TREATMENT OF SARCOIDOSIS-ASSOCIATED PULMONARY-HYPERTENSION WITH CORTICOSTEROIDS

被引：36
|
作者：
RODMAN, DM
LINDENFELD, J
机构：
来源：
CHEST | 1990年 / 97卷 / 02期
关键词：
D O I：
10.1378/chest.97.2.500
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
We report a case of sarcoidosis presenting with cor pulmonale of a greater sensitivity than would be expected from the degree of hypoxia and pulmonary fibrosis. Right heart catheterization revealed that mean pulmonary artery pressure was markedly increased (42 mm Hg), was not reduced by supplemental oxygen, but was reduced significantly (25 mm Hg) after 16 weeks of therapy with corticosteroids. Improvement in symptoms and pulmonary function was maintained for an 18-month period of observation after cessation of corticosteroid therapy.
引用
收藏
页码：500 / 502
页数：3
相关论文
共 50 条
  • [1] Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan
    Foley, Raymond J.
    Metersky, Mark L.
    [J]. RESPIRATION, 2008, 75 (02) : 211 - 214
  • [2] Bosentan For The Treatment Of Sarcoidosis-Associated Pulmonary Hypertension
    Palmero, V.
    Sulica, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [3] Sarcoidosis-Associated Pulmonary Hypertension
    Huitema, Marloes P.
    Mathijssen, Harold
    Mager, Johannes J.
    Snijder, Repke J.
    Grutters, Jan C.
    Post, Marco C.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (05) : 659 - 672
  • [4] Sarcoidosis-associated pulmonary hypertension
    Cordova, Francis C.
    D'Alonzo, Gilbert
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (05) : 531 - 537
  • [5] Sarcoidosis-Associated Pulmonary Hypertension
    Shlobin, Oksana A.
    Baughman, Robert P.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (04) : 450 - 462
  • [6] Sarcoidosis-Associated Pulmonary Hypertension
    Israel-Biet, Dominique
    Pastre, Jean
    Nunes, Hilario
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [7] Treatment of sarcoidosis-associated pulmonary arterial hypertension with Bosentan
    Bimenyuy, Christian
    Bourbonnais, Julie
    Samavati, Lobelia
    [J]. CHEST, 2007, 132 (04) : 482S - 483S
  • [8] Management of Sarcoidosis-associated Pulmonary Hypertension
    Ho, Jim Q.
    Kuschner, Ware G.
    [J]. CLINICAL MEDICINE & RESEARCH, 2020, 18 (2-3) : 55 - 55
  • [9] Aetiology of sarcoidosis-associated pulmonary hypertension
    Mathijssen, H.
    Huitema, M. P.
    Bakker, A. L. M.
    Smits, F.
    Snijder, R. J.
    Mager, H. J.
    Grutters, J. C.
    Post, M. C.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2231 - 2231
  • [10] An update on sarcoidosis-associated pulmonary hypertension
    Bandyopadhyay, Debabrata
    Humbert, Marc
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 582 - 590
12345